BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11198929)

  • 21. Phosphorothioate-capped antisense oligonucleotides to Ras GAP inhibit cell proliferation and trigger apoptosis but fail to downregulate GAP gene expression.
    White JR; Gordon-Smith EC; Rutherford TR
    Biochem Biophys Res Commun; 1996 Oct; 227(1):118-24. PubMed ID: 8858112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.
    Braasch DA; Liu Y; Corey DR
    Nucleic Acids Res; 2002 Dec; 30(23):5160-7. PubMed ID: 12466540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformationally restricted carbohydrate-modified nucleic acids and antisense technology.
    Herdewijn P
    Biochim Biophys Acta; 1999 Dec; 1489(1):167-79. PubMed ID: 10807006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of a regulatory region on the 5'-untranslated region of human hepatoma HepG2 gamma-glutamyltransferase mRNA and response to dexamethasone and antisense oligonucleotide treatment.
    Diederich M; Wellman M; Siest G
    FEBS Lett; 1994 Dec; 356(2-3):307-10. PubMed ID: 7805861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oligonucleotides complementary to the mRNA of the c-HA-ras gene suppress human cell proliferation in culture].
    Debus N; Griaznov SM; Berdichevskiĭ FB
    Dokl Akad Nauk SSSR; 1990; 313(2):491-4. PubMed ID: 2289400
    [No Abstract]   [Full Text] [Related]  

  • 26. Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo.
    Faria M; Spiller DG; Dubertret C; Nelson JS; White MR; Scherman D; Hélène C; Giovannangeli C
    Nat Biotechnol; 2001 Jan; 19(1):40-4. PubMed ID: 11135550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
    Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
    Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of antisense oligonucleotides comprising 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA): specificity, potency, and duration of activity.
    Ferrari N; Bergeron D; Tedeschi AL; Mangos MM; Paquet L; Renzi PM; Damha MJ
    Ann N Y Acad Sci; 2006 Oct; 1082():91-102. PubMed ID: 17145930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis.
    Buck AC; Shen C; Schirrmeister H; Schmid-Kotsas A; Munzert G; Guhlmann A; Mehrke G; Klug N; Gross HJ; Bachem M; Reske SN
    Cancer Biother Radiopharm; 2002 Jun; 17(3):281-9. PubMed ID: 12136520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified antisense oligonucleotides directed against tumor necrosis factor receptor type I inhibit tumor necrosis factor alpha-mediated functions.
    Ojwang JO; Mustain SD; Marshall HB; Rao TS; Chaudhary N; Walker DA; Hogan ME; Akiyama T; Revankar GR; Peyman A; Uhlmann E; Rando RF
    Biochemistry; 1997 May; 36(20):6033-45. PubMed ID: 9166774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
    Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
    Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
    Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
    Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription.
    DeMoor JM; Vincent MD; Collins OM; Koropatnick J
    Exp Cell Res; 1998 Aug; 243(1):11-21. PubMed ID: 9716444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides.
    Gutierrez AJ; Matteucci MD; Grant D; Matsumura S; Wagner RW; Froehler BC
    Biochemistry; 1997 Jan; 36(4):743-8. PubMed ID: 9020771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels.
    Smetsers TF; van de Locht LT; Pennings AH; Wessels HM; de Witte TM; Mensink EJ
    Leukemia; 1995 Jan; 9(1):118-30. PubMed ID: 7845006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological activity of hexitol nucleic acids targeted at Ha-ras and intracellular adhesion molecule-1 mRNA.
    Vandermeeren M; Préveral S; Janssens S; Geysen J; Saison-Behmoaras E; Van Aerschot A; Herdewijn P
    Biochem Pharmacol; 2000 Mar; 59(6):655-63. PubMed ID: 10677582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
    Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET
    Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stable transfection of U937 cells with sense or antisense RXR-alpha cDNA suggests a role for RXR-alpha in the control of monoblastic differentiation induced by retinoic acid and vitamin D.
    Brown TR; Stonehouse TJ; Branch JS; Brickell PM; Katz DR
    Exp Cell Res; 1997 Oct; 236(1):94-102. PubMed ID: 9344589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.
    Smetsers TF; Skorski T; van de Locht LT; Wessels HM; Pennings AH; de Witte T; Calabretta B; Mensink EJ
    Leukemia; 1994 Jan; 8(1):129-40. PubMed ID: 8289478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticulate systems for the delivery of antisense oligonucleotides.
    Lambert G; Fattal E; Couvreur P
    Adv Drug Deliv Rev; 2001 Mar; 47(1):99-112. PubMed ID: 11251248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.